Request Sample Inquiry
In-vitro Lung Model Market

In-vitro Lung Model Market

In-vitro Lung Model Market - Global Industry Assessment & Forecast

img
Biotechnology and Life Sciences
Number Of Pages # Pages:

120

Base Year:

2022

Date

Mar - 2023

Format:

PDF XLS PPT

Report Code:

VMR-1337

Segments Covered
  • By Type By Type 2D Cell Models, 3D Cell Models
  • By Application By Application Drug Screening, Toxicology, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 321.20 Million
Revenue 2030Revenue 2030: USD 1112.58 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 16.80%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global In-vitro Lung Model Market - Segment Analysis
    1. Overview
    2. Global In-vitro Lung Model Market, 2016 - 2028 (USD Million)
    3. Global In-vitro Lung Model Market - by Type
      1. By 2D Cell Models
      2. By 3D Cell Models
    4. Global In-vitro Lung Model Market - by Application
      1. By Drug Screening
      2. By Toxicology
      3. By Others
    5. Global In-vitro Lung Model Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America In-vitro Lung Model Market - Segment Analysis
    1. Overview
    2. North America In-vitro Lung Model Market, 2016 - 2028 (USD Million)
    3. North America In-vitro Lung Model Market, by Type
      1. By 2D Cell Models
      2. By 3D Cell Models
    4. North America In-vitro Lung Model Market, by Application
      1. By Drug Screening
      2. By Toxicology
      3. By Others
    5. North America In-vitro Lung Model Market, by Country
      1. U.S.
        1. U.S. In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. U.S. In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      2. Canada
        1. Canada In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Canada In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      3. Mexico
        1. Mexico In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Mexico In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
  5. Europe In-vitro Lung Model Market - Segment Analysis
    1. Overview
    2. Europe In-vitro Lung Model Market, 2016 - 2028 (USD Million)
    3. Europe In-vitro Lung Model Market, by Type
      1. By 2D Cell Models
      2. By 3D Cell Models
    4. Europe In-vitro Lung Model Market, by Application
      1. By Drug Screening
      2. By Toxicology
      3. By Others
    5. Europe In-vitro Lung Model Market, by Country
      1. Germany
        1. Germany In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Germany In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      2. UK
        1. UK Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. UK Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      3. France
        1. France In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. France In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      4. Spain
        1. Spain In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Spain In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      5. Italy
        1. Italy In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Italy In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      6. BENELUX
        1. BENELUX In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. BENELUX In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      7. Rest of Europe
        1. Rest Of Europe In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Rest Of Europe In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
  6. Asia Pacific In-vitro Lung Model Market - Segment Analysis
    1. Overview
    2. Asia Pacific In-vitro Lung Model Market, 2016 - 2028 (USD Million)
    3. Asia Pacific In-vitro Lung Model Market, by Type
      1. By 2D Cell Models
      2. By 3D Cell Models
    4. Asia Pacific In-vitro Lung Model Market, by Application
      1. By Drug Screening
      2. By Toxicology
      3. By Others
    5. Asia Pacific In-vitro Lung Model Market, by Country
      1. China
        1. China In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. China In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      2. Japan
        1. Japan In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Japan In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      3. India
        1. India In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. India In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      4. South Korea
        1. South Korea In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. South Korea In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      5. South East Asia
        1. South East Asia In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. South East Asia In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Rest of Asia Pacific In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
  7. Latin America In-vitro Lung Model Market - Segment Analysis
    1. Overview
    2. Latin America In-vitro Lung Model Market, 2016 - 2028 (USD Million)
    3. Latin America In-vitro Lung Model Market, by Type
      1. By 2D Cell Models
      2. By 3D Cell Models
    4. Latin America In-vitro Lung Model Market, by Application
      1. By Drug Screening
      2. By Toxicology
      3. By Others
    5. Latin America In-vitro Lung Model Market, by Country
      1. Brazil
        1. Brazil In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Brazil In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      2. Argentina
        1. Argentina In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Argentina In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      3. Rest of Latin America
        1. Rest of Latin America In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Rest of Latin America In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
  8. Middle East & Africa In-vitro Lung Model Market - Segment Analysis
    1. Overview
    2. Middle East & Africa In-vitro Lung Model Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa In-vitro Lung Model Market, by Type
      1. By 2D Cell Models
      2. By 3D Cell Models
    4. Middle East & Africa In-vitro Lung Model Market, by Application
      1. By Drug Screening
      2. By Toxicology
      3. By Others
    5. Middle East & Africa In-vitro Lung Model Market, by Country
      1. GCC Countries
        1. GCC Countries In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. GCC Countries In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      2. South Africa
        1. South Africa In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. South Africa In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa In-vitro Lung Model Market, By Type
          1. By 2D Cell Models
          2. By 3D Cell Models
        2. Rest of Middle East & Africa In-vitro Lung Model Market, By Application
          1. By Drug Screening
          2. By Toxicology
          3. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Epithelix (Switzerland)
    2. MatTek Corporation (US)
    3. Lonza (Switzerland)
    4. ATCC (US)
    5. InSphero (Switzerland)
    6. Emulate (US)
    7. AlveoliX (Switzerland)
    8. Oncotheis (Switzerland)
    9. Insphero (Switzerland)
    10. TissUse (Switzerland)
    11. Mimetas (Netherlands)
    12. and CN Bio Innovations (UK).
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 21-Feb-2022
Lung in Vitro Model Market to Reach Valuation of USD 976.1 Million by 2028 - Rising Emphasis on Developing Alternatives for Animal Testing Models is Expected to Boost the Revenue for the Market
FAQ
Frequently Asked Question

  • The global In-vitro Lung Model valued at USD 321.20 Million in 2022 and is expected to reach USD 1112.58 Million in 2030 growing at a CAGR of 16.80%.

  • The prominent players in the market are Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK)..

  • The market is project to grow at a CAGR of 16.80% between 2023 and 2030.

  • The driving factors of the In-vitro Lung Model include

    • Rising Prevalence of Lung Diseases and Increasing Research on Lung Disorders

  • North America was the leading regional segment of the In-vitro Lung Model in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy